Growth Prospects Ahead For Johnson & Johnson (JNJ)

In “Squawk on the Street” on CNBC, the co-anchor of the show Jim Cramer, comments on the Q2 earnings of Johnson & Johnson (NYSE:JNJ), which beats analysts expectations, and the performance of its CEO, Alex Gorsky.

Johnson & Johnson (JNJ)

Commenting on the performance of the company, Cramer said:

“More about Pharma sales, that pretty incredible, domestic sales up 36%, a 2 cents raise, I am sure that time people are going to say, listen that’s not enough. You want to bet against Gorsky? (CEO of Johnson & Johnson) or sellout Gorsky? Go ahead, knock yourself out, it’s a mistake, this company is going higher.”

On the fact that the Johnson & Johnson (NYSE:JNJ) stock is up 8% since Q1 and a lot of other stocks also being up by 8% since Q1, Cramer said:

“Look, it’s a good drug stock and I think that what happens is that people say: you know what?  That’s not good enough, and then three weeks from now, they say, wait a second, of all the drug companies reported, Johnson & Johnson had the fastest growth. Now it’s pretty amazing.  The only other one that really touches it, is Allergan, and obviously Allegan is in play.”

According to Cramer, Johnson & Johnson (NYSE:JNJ) is a good drug stock to bet on looking at its growth prospects and according to him Allergan, Inc. (NYSE:AGN) is another drug stock that is similar to Johnson & Johnson (NYSE:JNJ) in terms of faster growth going ahead.

Meanwhile, Johnson & Johnson (NYSE:JNJ) announced on July 15, 2014 that the growing sales of its Hepatitis C drug has boosted its revenue as well as earnings for the second Quarter. The company has also raised its full-year earnings guidance to $5.85 to $5.92 a share compared to its previous guidance of $5.80 to $5.90 a share.

As part the announcement of latest results, the company’s sales of $19.5 billion for the second quarter of 2014, showed an increase of 9.1% compared to the same period last year. Moreover, net earnings i.e. excluding special items, were $4.8 billion, showing an increase of 11.3% over the same period for 2013.


Disclosure: none

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!